ClinicalTrials.Veeva

Menu

A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum

McNeil-PPC logo

McNeil-PPC

Status and phase

Completed
Phase 4

Conditions

Dental Pellicle

Treatments

Drug: 4 mg nicotine gum
Drug: 2 mg nicotine gum

Study type

Interventional

Funder types

Industry

Identifiers

NCT00174499
A6431088

Details and patient eligibility

About

The purpose of this research study is to evaluate the effects on existing tooth stain of nicotine gum. The study will enroll adults who have visible tooth staining.

Full description

This was a 6-week, open-label, single-center study conducted in 78 subjects who were smokers with visible staining of teeth and who were motivated to quit smoking through use of Nicorette Freshmint gum.

The subjects were assigned, per label instructions, to either Nicorette Freshmint gum 2 mg or 4 mg based on the number of cigarettes smoked per day. Subjects who smoked at least 25 or more cigarettes per day were assigned to the 4 mg gum group; those who smoked less than 25 cigarettes per day were assigned to the 2 mg gum group.

A total of 3 study visits were planned: Screening/Baseline, Week 2 and Week 6. A telephone screening prior to Baseline and the Screening/Baseline visit was performed to confirm subject eligibility. At each visit an oral examination, including a stain index measurement used to rate tooth-staining (MacPherson Modification of the Lobene Stain Index), was conducted; and smoking status and motivation to quit smoking were assessed. The safety evaluation at each visit included an oral tissue assessment in addition to assessment for any adverse events.

Enrollment

78 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • daily smokers for at least one year
  • motivated to quit smoking
  • normal chewing ability
  • willing to refrain from a dental prophylaxis for the duration of the study
  • total extrinsic facial tooth stain score > or = to 28, according to the MacPherson Modification of the Lobene Stain Index

Exclusion criteria

  • < 20 natural teeth
  • inadequate oral hygiene

Trial design

78 participants in 2 patient groups

1
Experimental group
Description:
2 mg nicotine gum
Treatment:
Drug: 2 mg nicotine gum
2
Experimental group
Description:
4 mg nicotine gum
Treatment:
Drug: 4 mg nicotine gum

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems